|
|
the impact of administering (s)-4-[1-(2, 3-dimethylphenyl) ethyl]-1h-imidazole (dexmedetomidine) during surgery on immediate and long-term pain after simple mastectomy: a systematic review
|
|
|
|
|
نویسنده
|
rousta fariborz ,sharifi ali
|
منبع
|
progress in chemical and biochemical research - 2024 - دوره : 7 - شماره : 1 - صفحه:100 -113
|
چکیده
|
This systematic review will evaluate the impact of administering dexmedetomidine during surgery on immediate and longterm pain outcomes after simple mastectomy. by synthesizing the available evidence, the review aims to provide a comprehensive understanding of the potential benefits of (s)-4-[1-(2,3- dimethylphenyl)ethyl]-1h-imidazole: dexmedetomidine in this specific surgical context and inform clinical practice. material and methods: an extensive exploration of electronic databases, specifically pubmed, embase, and the cochrane library, was undertaken to pinpoint pertinent studies (during 2000-2023). the search methodology encompassed a fusion of medical subject headings (mesh) terms and keywords pertinent to dexmedetomidine, mastectomy, simple mastectomy and postoperative pain. the search was confined to studies available in the english language. moreover, the reference lists of identified articles and conference proceedings underwent manual scrutiny to unearth any supplementary studies of relevance. results: regarding postoperative pain intensity, the majority of studies reported significantly lower pain scores in the (s)-4-[1-(2,3- dimethylphenyl)ethyl]-1h-imidazole: dexmedetomidine group compared to the control group at various time points during the immediate postoperative period(p˂0.05). (s)-4-[1-(2,3- dimethylphenyl)ethyl]-1h-imidazole: dexmedetomidine infusion was associated with reduced pain intensity(p˂0.05), both at rest and with movement(p˃0.05), indicating improved analgesia(p˂0.05). conclusion: administering (s)-4-[1-(2,3-dimethylphenyl)ethyl]-1himidazole: dexmedetomidine during surgery for simple mastectomy may have a positive impact on immediate and long-term pain outcomes. (s)-4- [1-(2,3-dimethylphenyl)ethyl]-1h-imidazole: dexmedetomidine infusion is associated with reduced postoperative pain intensity, decreased opioid consumption, prolonged duration of analgesia, and improved patient satisfaction.
|
کلیدواژه
|
dexmedetomidine ,simple mastectomy ,pain
|
آدرس
|
tabriz university of medical sciences, school of medicine, imam reza medical research & training hospital, department of cardiovascular surgery, iran, tabriz university of medical sciences, school of medicine, imam reza medical research & training hospital, department of general surgery, iran
|
پست الکترونیکی
|
vahideh_rahmani@yahoo.com
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|